In conclusion, this study revealed that PD-L1 gene is involved in the occurrence and development of pancreatic cancer as a pro-oncogene through the use of relevant bioinformatics methods, which is helpful to improve the monitoring strategy for the recurrence of pancreatic cancer patients after treatment, thus providing a new idea for early diagnosis and early treatment in clinical practice. This evidence concerns the gene CD274 and pancreatic neoplasm.